Society of Thoracic Surgeons - Critical Care

NOVEMBER 28, 2023

Video How Sweet It Isn't: Perioperative CABG Diabetes Management dkaczmarek Tue, 11/28/2023 - 11:48 Perioperative management of diabetes in CABG patients is an evolving topic. Presenters: Matthew Georgis, MD Wayne State University Cardiothoracic Surgery Frank Baciewicz Wayne State University Cardiothoracic Surgery Duration 7 min.

Diabetes 52

Diabetes Cardiothoracic Critical Care 52

Journal of Cardiothoracic Surgery

MARCH 20, 2025

We evaluated the surgical outcomes in three groups of individuals with diabetes mellitus (DM), end-stage renal disease (ESRD), and on (ONCAB) vs. off-pump (OPCAB) coronary artery bypass grafting (CABG).

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Diabetes Outcomes 40

GEMMS

MARCH 28, 2023

Cardiology solutions have been a godsend for cardiothoracic surgeons and medical personnel, relieving the stress on cardiology departments and providing better patient care. It’s essential for cardiology professionals to have access to a range of diagnostic tests and monitoring functions, which these systems provide.

Patient Care 52

Patient Care Quality of Life Technology Medicaid 52

Dr. Smith's ECG Blog

APRIL 9, 2023

Submitted by Ali Khan MD and James Mantas MD, MS, written by Pendell Meyers A man in his 50s with history of diabetes, hypertension, and tobacco use presented to the ED with 24 hours of worsening left sided chest pain radiating to the back, characterized as squeezing and pinching, associated with shortness of breath.

Chest Pain 52

Chest Pain Ischemia Stenosis Pulmonary 52

Journal of Cardiothoracic Surgery

FEBRUARY 2, 2024

Univariate predictors of prolonged ICU stays included a left atrial diameter of > 4& cm (P < 0.001),chronic obstructive airway disease COPD (P = 0.005), hypertension (P = 0.006), diabetes mellitus (P = 0.009), having coronary stents (P = 0.006), B-blockers use (..)

ICU 40

ICU Atrial Fibrillation Hospital Risk Factors 40

DAIC

JUNE 26, 2024

Getty Images milla1cf Wed, 06/26/2024 - 18:59 June 26, 2024 — Semaglutide , a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options.

Preserved Ejection Fraction 105

Preserved Ejection Fraction Obesity BMI Heart Failure 105

Cardiometabolic Health Congress

MARCH 8, 2024

Dr. Lala-Trindade serves as the director of Heart Failure Research and leads the Data Coordinating Center for the NHLBI Cardiothoracic Surgery Network. She researches strategies to treat diabetes mellitus and reduce the risk of cardiovascular, renal, and other diabetes-related complications.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59